OpenAI acquisition of Orchestra Bio for life-sciences expansion

Description OpenAI is expanding into life sciences through its acquisition of biotechnology firm Orchestra Bio. Overview OpenAI acquired Orchestra Bio to add biological-study and drug-development coordination capabilities to its artificial intelligence operations. The transaction lets OpenAI apply its models to life-sciences… Read more